Pharmahungary Group as a Hungarian SME is ready for Horizon 2020 applications and are offering innovative preclinical and clinical R&D services.
Pharmahungary Group joins COST Action titled “Realising the therapeutic potential of novel cardioprotective therapies”.
Pharmahungary Group scientific management will attend the 34th Annual Meeting of the European Section of the ISHR in Hamburg, Germany, July 24-27.
Pharmahungary Group Founder & CEO will hold scientific presentations at European Society of Cardiology Congress.
Lecture of Pharmahungary Group Clinical Director on Advanced Training Course for Clinical Research Associates (CRA) titled “Medical Devices, Introduction.”